A previous report showed that 80% or more of all cell cultures which were ultimately positive for influenza virus could be detected within 3 days by fluorescence microscopy (6). Our objective was to determine whether this approach could be used in a central laboratory to diagnose influenza for family physicians enrolled in the Centers for Disease Control sentinel practice influenza surveillance program. The physicians were requested to send throat swab specimens collected from their patients to a central laboratory (located in Las Vegas, Nev.) when they first observed increases in the number of influenzalike illnesses among their patients.
Influenza virus epidemics in the United States occur on a regular basis, causing a yearly average of about 20,000 deaths (K. J. Lui and A. P. Kendal, Am. J. Public Health, in press), about 250,000 hospitalizations, and increases in medical costs of about $300 million for hospitalization alone (2) . With increased emphasis on the use of antiviral agents for control of influenza A virus infection (1), a rapid, economical diagnostic system that is available to physicians regardless of their geographical location in relation to virus laboratories is needed.
A previous report showed that 80% or more of all cell cultures which were ultimately positive for influenza virus could be detected within 3 days by fluorescence microscopy (6) . Our objective was to determine whether this approach could be used in a central laboratory to diagnose influenza for family physicians enrolled in the Centers for Disease Control sentinel practice influenza surveillance program. The physicians were requested to send throat swab specimens collected from their patients to a central laboratory (located in Las Vegas, Nev.) when they first observed increases in the number of influenzalike illnesses among their patients.
Detailed instructions for the collection, processing, and mailing of specimens were provided to participating physicians along with a kit that included the following: (i) one Styrofoam shipping container with a cardboard sleeve; (ii) three 2-dram (3.5-g) specimen-collection vials containing 2 strains. The viruses isolated were the prevalent strains circulating in the nation at the time of specimen collection (3, 4) . During the 1985 to 1986 season, when sufficient numbers of isolates were obtained for analysis, laboratory diagnosis confirmed the presence of influenza B virus at or before the time of peak niorbidity (Fig. 1) .
The time in transit of specimens from physicians' offices to the central laboratory ranged from 1 to 18 days according to records supplied by the physicians. The average time in transit was 4.1 days for positive specimens and 5.2 days for negative specimens, suggesting that delays in shipment may have reduced isolation rates. There was no consistent relationship between transit time and either the distance traveled or the day of the week specimens were sent, but the longest transit times were from states on the East Coast.
On the average, results were reported 3 days after receipt. Of the specimens received, 5% were contaminated or were toxic to the cell cultures and were retreated and reinoculated, requiring an extra 1 to 2 days of handling. However, an equal percentage (5%) of specimens were positive within 48 h of inoculation.
The entire direct cost per specimen ranged from $12.00 to $16.00. These costs included specimen collection materials costs and shipping charges of $4.00, isolation and identification materials costs of $3.00, and charges for 20 to 30 min of technical time of about $5.00 to $9.00.
Rapid diagnosis of influenza is desirable at the onset of an outbreak to facilitate both vaccination and specific chemotherapy, particularly. for inadequately protected persons at high risk (1) . The influenza virus should be typed because antiviral therapy is directed solely against influenza A virus. Recently developed type-specific monoclonal antibodies have provided reagents suitable for identification (6 
